14 completed, 4 unknown, 3 terminated, 2 active not recruiting. 15 Not applicable, 3 Phase 3, 2 Phase 2, 1 Phase 1.
Follow this condition Literature Review of Peripheral Arterial Disease (PAD) trials Research Report on Peripheral Arterial Disease (PAD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodal Physiologic State Intelligence Study OMNIPHYS Multimodal Ultrasound Imaging System - Heart Failure, Cardiomyopathies | Enrolling by invitation | Truway Health, Inc. | 25000 | 2026-09-02 | 2026-09-10 | |
| Automated ABPI in Peripheral Arterial Disease a Pilot Study MESI mTablet, BlueDop vascular Expert (BlueDopVE) - Peripheral Arterial Disease (PAD), Ankle Brachial Index | Recruiting | Hull University Teaching Hospitals NHS Trust | 400 | 2026-06-24 | 2026-10-01 | |
| Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia Analysis of GLP-1 receptor expression - Peripheral Arterial Disease (PAD), Claudication, Intermittent | Not yet recruiting | University Hospital, Strasbourg, France | 50 | 2026-06-01 | 2026-01-14 | |
| Recreational Team Handball Programme for Patients With Peripheral Arterial Disease Recreational team handball programme - Peripheral Arterial Disease (PAD) | Not applicable | Not yet recruiting | University Institute of Maia | 60 | 2026-05-14 | 2026-05-13 |
| An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs Peripheral Arterial Disease (PAD) | Completed | Bayer | 1500 | 2025-08-12 | 2026-08-06 | |
| Electromagnetic Therapy, Peripheral Vascular Diseases, Diabetes Low-frequency pulsed electromagnetic therapy plus interval exercise training program, Placebo low-frequency pulsed electromagnetic therapy plus interval exercise training program - Peripheral Arterial Disease (PAD), Diabete Type 2 | Not applicable | Completed | Ashraf Abdelaal | 60 | 2025-07-01 | 2026-10-13 |
| Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease Aspirin, Clopidogrel, Ticagrelor - Peripheral Arterial Disease (PAD), Amputation | Not applicable | Recruiting | Massachusetts General Hospital | 484 | 2025-04-29 | 2026-09-11 |
| Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial Pulse Intravascular Lithotripsy (Pulse IVL) - Peripheral Arterial Disease (PAD) | Not applicable | Active not recruiting | Amplitude Vascular Systems, Inc. | 115 | 2024-09-05 | 2026-02-18 |
| VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) SMS messages, Telephone-based support calls, GP Education - Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Heart Disease (CHD) | Not applicable | Terminated | Monash University | 6 | 2023-11-17 | 2025-01-27 |
| A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. Spot stent system, Self-expanding peripheral stent system - Peripheral Vascular Disease (PVD), Peripheral Arterial Disease (PAD) | Not applicable | Unknown | Acotec Scientific Co., Ltd | 196 | 2022-08-17 | 2023-11-29 |
| Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia Drug eluting Balloon - Peripheral Arterial Disease (PAD) | Not applicable | Unknown | Zhejiang Zylox Medical Device Co., Ltd. | 200 | 2022-05-04 | 2022-08-12 |
| A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD Therapeutic ultrasound (TUS) - Peripheral Arterial Disease (PAD) | Not applicable | Active not recruiting | Vibrato Medical, Inc. | 12 | 2022-01-14 | 2023-05-23 |
| Home-based Exercise Therapy for Patients With PAD WalkingPad plus Psychological Intervention - PsyWPad Group, WalkingPad plus Virtual Assistant - CyberWPad Group, WalkingPad group - Paper WPad Group - Peripheral Arterial Disease (PAD), Intermittent Claudication | Not applicable | Unknown | Centro Hospitalar do Porto | 200 | 2021-02-09 | 2023-02-10 |
| Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk Rivaroxaban 2.5 MG [Xarelto] - Coronary Artery Disease (CAD), Peripheral Arterial Disease (PAD) | Completed | Maatschap Cardiologie Zwolle | 645 | 2020-12-21 | 2023-09-28 | |
| ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease ULTRASCORE™ Focused Force PTA Balloon - Peripheral Arterial Disease (PAD) | Unknown | Michael Lichtenberg, MD | 80 | 2020-10-23 | 2022-03-31 | |
| The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM REX-001, Placebo - Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM) | Phase 3 | Terminated | Ixaka Ltd | 49 | 2017-04-25 | 2023-03-16 |
| The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM REX-001, Placebo - Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM) | Phase 3 | Terminated | Ixaka Ltd | 3 | 2017-04-05 | 2021-05-07 |
| Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses Zilver® Paclitaxel-Eluting Peripheral Stent, Zilver® Paclitaxel-Eluting Peripheral Stent with slower-dissolving polymer-free paclitaxel coating, Zilver® Paclitaxel-Eluting Peripheral Stent with higher-dose polymer-free paclitaxel coating - Peripheral Arterial Disease (PAD) | Not applicable | Completed | Cook Group Incorporated | 176 | 2017-02-21 | 2024-04-05 |
| Evaluation of WIRION™ EPS in Lower Extremities Arteries WIRION - Peripheral Arterial Disease (PAD) | Not applicable | Completed | Gardia Medical | 103 | 2016-05-01 | 2018-03-15 |
| Zilver Flex Post-Market Study in Japan Zilver Flex Bare Metal Stent - Peripheral Arterial Disease (PAD) | Not applicable | Completed | Cook Group Incorporated | 239 | 2012-05-01 | 2018-03-30 |
Showing 20 of 28. Sign in to see all of them.
Peripheral Arterial Disease (28) · Cardiovascular Diseases (4) · Chronic Limb-Threatening Ischemia (3) · Diabetes Mellitus (3) · Diabetes Mellitus, Type 2 (3) · Intermittent Claudication (3) · Peripheral Vascular Diseases (3) · Atherosclerosis (2) · Diabetes Mellitus, Type 1 (2) · Acute Kidney Injury (1) · Aortic Diseases (1) · Arterial Occlusive Diseases (1) · Cardiomyopathies (1) · Cerebrovascular Disorders (1) · Clinical Deterioration (1)
Arteriosclerosis (28) · Arterial Occlusive Diseases (27) · Vascular Diseases (27) · Atherosclerosis (26) · Peripheral Vascular Diseases (25) · Cardiovascular Diseases (24) · Pathological Conditions, Signs and Symptoms (7) · Disease Attributes (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Pathologic Processes (4) · Signs and Symptoms (4) · Chronic Disease (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3)
Aspirin (2) · Clopidogrel (2) · Rivaroxaban (2) · Behavior Therapy (1) · Ferrosoferric Oxide (1) · Mutagenesis, Insertional (1) · Stents (1) · Thrombelastography (1) · Ticagrelor (1) · Ticlopidine (1) · Ultrasonic Therapy (1) · inclacumab (1)
Cook Group Incorporated (5) · Ixaka Ltd (2) · AMAG Pharmaceuticals, Inc. (1) · Acotec Scientific Co., Ltd (1) · Amplitude Vascular Systems, Inc. (1) · Ashraf Abdelaal (1) · AstraZeneca (1) · Bayer (1) · Centro Hospitalar do Porto (1) · Gardia Medical (1) · Hoffmann-La Roche (1) · Hull University Teaching Hospitals NHS Trust (1) · Maatschap Cardiologie Zwolle (1) · Massachusetts General Hospital (1) · Medtronic Endovascular (1)
United States (7) · Germany (6) · Portugal (4) · Japan (3) · Netherlands (3) · Australia (2) · China (2) · Czechia (2) · France (2) · Hungary (2) · Spain (2) · United Kingdom (2) · Belgium (1) · Canada (1) · Greece (1)
Gilbert Wagener, MD (2) · Michael D Dake, MD (2) · Christopher Metzger, MD (1) · Claudio Borghi (1) · Claudio Cimminiello (1) · Gavin C Solomon, M.D. (1) · Gerald Zemel, MD (1) · Gunnar Tepe, Prof Dr. Med (1) · Guo Wei, MD (1) · Hiroshi Shigematsu, Head Professor/MD/PhD (1) · Ivone Heitor, PhD (1) · Jens Ricke, MD (1) · Mario Mangrella (1)
PMID 20687927, PMID 21981988, PMID 23555538, PMID 25472980, PMID 26062950, PMID 26847118, PMID 29326153, PMID 30411151, PMID 30690141, PMID 31195825, PMID 31543165, PMID 33025243, PMID 33084502, PMID 35436974, PMID 36137674, PMID 38075956, PMID 42573020